An Unusual Case of Stroke: A Case Report and Review of Current Literature


Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory vascular disease. FMD once considered rare, is increasingly a condition recognised as an incidental finding. It is an important cause of stroke especially in younger, female patients and therefore a high index of suspicion is required. FMD has distinct pathological findings along with some pathognomonic angiographic findings (“string of beads” appearance). The mainstay of cerebrovascular FMD treatment is antiplatelet therapy but intervention with percutaneous transluminal angioplasty is indicated under some circumstances. We present an interesting case of a woman in her 60 s who underwent extensive investigation to identify the underlying aetiology of her stroke.

Share and Cite:

Mackett, A. , Das, S. , Chowdhury, M. and Phillips, P. (2015) An Unusual Case of Stroke: A Case Report and Review of Current Literature. Open Journal of Internal Medicine, 5, 5-10. doi: 10.4236/ojim.2015.52002.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Plouin, P.F., Perdu, J., La Batide-Alanore, A., Boutouyrie, P., Gimenez-Roqueplo, A.P. and Jeunemaitre, X. (2007) Fibromuscular Dysplasia. Orphanet Journal of Rare Diseases, 2, 28.
[2] Persu, A., Touzé, E., Mousseaux, E., Barral, X., Joffre, F. and Plouin, P.F. (2012) Diagnosis and Management of Fibromuscular Dysplasia: An Expert Consensus. European Journal of Clinical Investigation, 42, 338-347.
[3] Cragg, A.H., Smith, T.P., Thompson, B.H., Maroney, T.P., Stanson, A.W., Shaw, G.T., Hunter, D.W. and Cochran, S.T. (1989) Incidental Fibromuscular Dysplasia in Potential Renal Donors: Long-Term Clinical Follow-Up. Radiology, 172, 145-147.
[4] Hendricks, N.J., Matsumoto, A.H., Angle, J.F., Baheti, A., Sabri, S.S., Park, A.W., et al. (2014) Is Fibromuscular Dysplasia Underdiagnosed? A Comparison of the Prevalence of FMD Seen in CORAL Trial Participants versus a Single Institution Population of Renal Donor Candidates. Vascular Medicine, 19, 363-367.
[5] Neymark, E., LaBerge, J.M., Hirose, R., Melzer, J.S., Kerlan Jr., R.K., Wilson, M.W. and Gordon, R.L. (2000) Arteriographic Detection of Renovascular Disease in Potential Renal Donors: Incidence and Effect on Donor Surgery. Radiology, 214, 755-760.
[6] Olin, J.W., Froehlich, J., Gu, X., Bacharach, J.M., Eagle, K., Gray, B.H., et al. (2012) The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients. Circulation, 125, 3182-3190.
[7] Sang, C.N., Whelton, P.K., Hamper, U.M., Connolly, M., Kadir, S., White, R.I., et al. (1989) Etiologic Factors in Renovascular Fibromuscular Dysplasia: A Case-Control Study. Hypertension, 14, 472-479.
[8] Leadbetter, W. and Burkland, L. (1938) Hypertension in Unilateral Renal Disease. Journal of Urology, 39, 611-626.
[9] McCormack, L., Hazard, J. and Poutasse, E. (1958) Obstructive Lesions of the Renal Artery Associated with Remediable Hypertension. American Journal of Pathology, 34, 582.
[10] Harrison Jr., E.G. and McCormack, L.J. (1971) Pathologic Classification of Renal Arterial Disease in Renovascular Hypertension. Mayo Clinic Proceedings, 46, 161-167.
[11] Stanley, J.C., Gewertz, B.L., Bove, E.L., Sottiurai, V. and Fry, W.J. (1975) Arterial Fibrodysplasia: Histopathologic Character and Current Etiologic Concepts. Archives of Surgery, 110, 561-566.
[12] Olin, J., Gornik, H., Bacharach, J.M., Biller, J., Fine, L.J., Gray, B.H., et al. (2014) AHA Scientific Statement Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions. A Scientific Statement from the American Heart Association. Circulation, 129, 1048-1078.
[13] Mettinger, K.L. (1982) Fibromuscular Dysplasia and the Brain, II: Current Concept of the Disease. Stroke, 13, 53-58.
[14] Cloft, H.J.A., Kallmes, D.F., Kallmes, M.H., Goldstein, J.H., Jensen, M.E. and Dion, J.E. (1998) Prevalence of Cerebral Aneurysms in Patients with Fibromuscular Dysplasia: A Reassessment. Journal of Neurosurgery, 88, 436-440.
[15] Rountas, C., Vlychou, M., Vassiou, K., Liakopoulos, V., Kapsalaki, E., Koukoulis, G., et al. (2007) Imaging Modalities for Renal Artery Stenosis in Suspected Renovascular Hypertension: Prospective Intraindividual Comparison of Color Doppler US, CT Angiography, GD-Enhanced MR Angiography, and Digital Subtraction Angiography. Renal Failure, 29, 295-302.
[16] Anzidei, M., Napoli, A., Zaccagna, F., Di Paolo, P., Saba, L., Cavallo Marincola, B., et al. (2012) Diagnostic Accuracy of Colour Doppler Ultrasonography, CT Angiography and Blood-Pool-Enhanced MR Angiography in Assessing Carotid Stenosis: A Comparative Study with DSA in 170 Patients. La Radiologia Medica, 117, 54-71.
[17] Furie, D.M. and Tien, R.D. (1994) Fibromuscular Dysplasia of Arteries of the Head and Neck: Imaging Findings. American Journal of Roentgenology, 162, 1205-1209.
[18] Brott, T.G., et al. (2011) ASA/AACF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients with Extracranial Carotid and Vertebral Artery Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Neurointerventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation, 124, 489-532.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.